Market analysis and notes for owners/operators/investors
Insights
-
The healthcare services deal market is bigger than M&A
Announced M&A is the narrowest layer of healthcare services supply. Establishment churn and provider retirement reveal a much larger succession market, and whether that supply becomes durable local capacity depends on who provides the care next.
Healthcare services Private equity Market analysis Provider operations DentistryRead → -
Healthcare PE consolidation: beyond the morality debate
A practical, ownership-neutral view of private equity in healthcare: where capital can help, where control can harm, and how providers, payers, patients, communities, and regulators should judge the tradeoffs.
Healthcare services Private equity Market analysis Provider operations RegulationRead → -
Private equity's AI underwriting & deployment gap: GTM playbook for AI-native Scalers
Private equity committed to AI faster than it can use it. Only about a fifth of portfolio companies have a use case in production, and deal teams are short on AI to underwrite with. For AI-native scalers, the space between underwriting and deployment is a distribution channel. The door most vendors walk through is the one that pays least.
AI Private equity Go-to-market DistributionRead → -
U.S. healthcare services landscape, ownership and control structure
A working map of U.S. healthcare services by care setting, specialty, workforce, and ownership control layer, with a read on how far private equity has actually gotten.
Healthcare services Market analysis Private equity Provider operations DentistryRead → -
Health AI distribution build vs. buy — illustrative math (Part 2 of 2)
Part 2 of the series. If an AI-native company set out to build Phreesia's ~4,700-organization distribution and ~$4B/yr payment rails from scratch, what would it cost in dollars and years? A bottoms-up look at replication cost and pace, the payments moat, customer lifetime value, a grounded re-rating (a 4-5x combined revenue multiple implying ~$2.4-3.0B), and the deal mechanics: reverse merger, PIPE, and the IPO window.
Healthcare AI Phreesia Patient access Valuation M&A DistributionRead → -
Health AI distribution build vs. buy — Phreesia primer (Part 1 of 2)
A profitable public incumbent with ~4,700 clinics and ~180M patient visits a year trades at ~1.3x forward sales, while the AI-native startups chasing the same buyers raise at 40 to 100x. The incumbent may be fairly priced as a stock. Its distribution, though, may be worth far more to an acquirer than to public shareholders. A primer on Phreesia, the numbers, and the build-vs-buy question that gap sets up.
Healthcare AI Phreesia Patient access Valuation M&ARead → -
The 2023 healthcare-AI map, three years later: who flourished, who flatlined
In June 2023, three authors mapped ~145 generative-AI healthcare startups. One of them, Jon Wang, then built Assort Health, now valued at $1.2B. We re-scored the whole map against public signals: about 38 flourished, ~31 were acquired, and only ~6 actually died. Here is what the three-year scorecard says about which healthcare-AI bets paid off.
Healthcare AI Market map Generative AI VentureRead → -
Healthcare voice AI isn't one market: a map of who the AI talks to
Microsoft, Abridge, Ambience, Suki, Assort Health, Hippocratic, Commure, Infinitus and the rest get lumped together as 'healthcare voice AI.' They're three different businesses, with different buyers, different moats, and different exposure to EHR bundling. This is a field map of the ambient and voice-agent landscape in 2026, sorted by who the AI talks to.
Healthcare AI Ambient AI Voice agents Market mapRead → -
What is generative AI clinical intelligence worth for clinical-trial recruitment?
A data-grounded estimate of what an ambient clinical intelligence layer is worth when it helps multi-site trials find, qualify, and fill candidates. Built from real ClinicalTrials.gov volume and sourced unit economics.
Ambient Clinical Intelligence Clinical trials Patient recruitment Healthcare AIRead → -
How ambient clinical AI can impact drug discovery and development
Most people file ambient AI under clinical documentation software. Its bigger biopharma job is a governed evidence layer for trial feasibility, patient finding, access friction, adherence, safety, and real-world evidence.
Healthcare AI Biopharma Clinical development Real-world evidenceRead → -
The missing provider encounter: why dental data belongs in the healthcare record
Dental offices run hundreds of millions of provider encounters a year. Count those visits as part of the healthcare data timeline and you can close care gaps, catch oral-systemic risk sooner, and coordinate patients better.
Dental Healthcare IT Care coordination Market analysisRead → -
The Denti-Cal cut that keeps getting deferred
California dental providers have spent two budget cycles bracing for Proposition 56 supplemental cuts that would drop Denti-Cal reimbursement by 40% to 80%. This walks through how the cut works, what the numbers mean, and why a second straight deferral leaves the cut on the books for 2027.
Denti-Cal California Policy Dental Provider economicsRead → -
The border operating system behind US / Mexico trade
US / Mexico trade runs on a less visible operating layer: customs brokers, freight forwarders, border drayage, cross-docks, warehouses, compliance teams, and the software that keeps documents, release status, and delivery promises in sync.
US-Mexico trade Customs brokerage Logistics Nearshoring Market analysisRead → -
Loan repayment and financial assistance programs for Medi-Cal dental providers
A sourced map of the public programs that help California dentists repay educational debt or get practice support in exchange for serving Medi-Cal and Denti-Cal patients. Covers what's active, what's coming, and what was recently suspended. Updated June 2026.
Medi-Cal Provider assistance Loan repayment Healthcare policy CaliforniaRead → -
A dozen vendors, one practice: what dental technology actually costs
Most dental owners can't say what they spend on software and IT. The spend scatters across a dozen vendors with no single bill. Here's the itemized, fully-sourced picture of what the technology stack actually costs.
Dental Practice economics Healthcare IT Market analysisRead →